MedTrace Logo

Pilot Study on Traditional Chinese Medicine and Food Allergy

NCT02490813 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-03-01

No results posted yet for this study

Summary

Recently, there has been an increasing interest in using traditional Chinese medicine for food allergy. The Harvard group has successfully demonstrated the Food Allergy Herbal Formula - FAHF2 completely blocked peanut-induced anaphylaxis in a murine model, and currently being studied in human. Therefore, in collaboration with the Institute of Chinese Medicine, CUHK, the investigators have developed a more simplified Chinese herbal formula - X (CHFX), containing four food-grade Chinese herbs, Wu-mei (Fructus Pruni Mume); Ling-zhi (Gonoderma); Huang-bai (Cortex Phellodendron) and Zhi-su (Perilla frutescens).

In the present study, the investigators would like to examine whether there is reduction in allergic symptoms in food challenge after administering the CHFX for 8 weeks. There will be pre- and post- CHFX food challenges and other related tests.

Conditions

  • Allergy to Fish
  • Allergy to Shrimp
  • Allergy to Crab

Interventions

DIETARY_SUPPLEMENT

Treatment - Chinese Herbal Formula - X

Wu Mei (Fructus Pruni Mume), Ling Zhi (Gonoderma), Huang Bai (Cortex Phellodendron), and Zhi Su (Perilla frutescens).

DIETARY_SUPPLEMENT

Placebo

Placebo will be starch with colorings

Sponsors & Collaborators

  • Chinese University of Hong Kong

    collaborator OTHER

  • Hong Kong Sanatorium & Hospital

    lead INDUSTRY

Principal Investigators

  • June Chan, Master · Hong Kong Sanatorium & Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-18
Primary Completion
2023-02-18
Completion
2023-02-18

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490813 on ClinicalTrials.gov